BGM Group Ltd. (BGM)
NASDAQ: BGM
· Real-Time Price · USD
11.40
-0.30 (-2.56%)
At close: May 05, 2025, 3:58 PM
11.20
-1.75%
After-hours: May 05, 2025, 05:41 PM EDT
-2.56% (1D)
| Bid | 11.15 |
| Market Cap | 2.2B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -57 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 11.39 |
| Volume | 2,436 |
| Avg. Volume (20D) | 22,313 |
| Open | 10.65 |
| Previous Close | 11.70 |
| Day's Range | 10.38 - 11.40 |
| 52-Week Range | 2.70 - 14.78 |
| Beta | 1.46 |
About BGM
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient f...
Sector Healthcare
IPO Date Jan 24, 2003
Employees 298
Stock Exchange NASDAQ
Ticker Symbol BGM
Website https://www.bgm.ltd
1 month ago
-1.07%
BGM Group shares are trading higher after the comp...
Unlock content with
Pro Subscription
5 months ago
BGM Group shares are trading higher after the company announced its acquisition of the intelligent platform of AIX Inc., valued at approximately $140 million.